Drugs / Symdeko
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03624101 | Dec 2018 → Oct 2019 | cystic fibrosis | University of Alabama at Birmingham | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Symdeko | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03624101 ↗ |
| Target | CFTR | “CFTR modulator” NCT03624101 ↗ |